Market Share of Global Monoclonal Antibodies Industry
The monoclonal antibodies market is expected to be highly competitive with the number of established companies in the market and the new incoming companies, which are investing heavily in R&D with new and advanced technologies. In the current scenario, COVID-19 and cancer therapeutics are expected to be the major domain of competition between the companies. Some of the major key players of the global monoclonal antibodies market are - Eli Lilly, F Hoffmann-La Roche, Merck, Amgen Inc., and Novartis AG, among others.
Monoclonal Antibodies Market Leaders
Merck Group
Eli Lilly and Company
Amgen Inc.
Novartis AG
F Hoffmann-La Roche AG
*Disclaimer: Major Players sorted in no particular order
